Epicrispr Biotechnologies Partners with Springbok Analytics to Integrate AI Muscle Analysis in First-in-Human FSHD Study
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Epicrispr Biotechnologies, a biotechnology company focused on developing curative therapies, today announced a partnership with Springbok Analytics to incorporate advanced, AI-driven muscle MRI imaging and analysis into its first-in-human clinical trial of EPI-321, a potential first-in-class treatment for facioscapulohumeral muscular dystrophy (FSHD).
The exploratory first-in-human global trial, recently cleared to begin in the United States and New Zealand, with additional regulatory approvals pending in other countries, is designed to evaluate the safety, tolerability, and biological activity of a single intravenous dose of EPI-321 in adults with FSHD. Through this collaboration, Springbok's advanced MRI-based muscle analytics will be integrated into the study to detect early, objective insights of muscle-level changes and generate high-resolution data.
'High-quality, objective data is essential in early clinical development, especially when advancing a first-in-class therapeutic,' said Amber Salzman, Ph.D., CEO, Epicrispr Biotechnologies. 'Springbok's automated muscle analysis gives us a detailed view of how EPI-321 may be impacting muscle tissue, strengthening our ability to assess early signals and shape future development.'
Springbok's proprietary technology uses proprietary AI to segment and quantify dozens of individual muscles from MRI scans, analyzing key biomarkers such as muscle volume, fat infiltration, and inflammation. These high-resolution analytics allow for rapid interpretation of complex imaging data to deliver actionable insights within hours and supporting data-driven clinical decisions from the earliest stages of development.
While MRI is an exploratory biomarker in this first-in-human trial, and not a primary study endpoint, the ability to detect subtle, muscle-level changes may be critical in shaping the design of future studies. In conditions like FSHD, where conventional functional endpoints may take longer to reflect therapeutic effect, quantitative muscle imaging offers an accelerated path to understanding biological response.
'Quantitative imaging has the potential to dramatically capture more information in early-stage trials in neuromuscular disease,' said Scott Magargee, CEO and Co-Founder, Springbok Analytics. 'We're proud to support Epicrispr as it pioneers a new therapeutic modality for FSHD and advances the role of imaging biomarkers in clinical development.'
Springbok's Contributions to the EPI-321 Study Include:
Streamlined Imaging Protocols: Enabling whole-body MRI to assess muscle volume and fat infiltration in under 45 minutes.
High-Resolution Analytics: Automated segmentation and quantification of muscle volume, fat content, and inflammation across dozens of muscle groups.
Scalability & Support: A robust quality management system and turnkey onboarding processes to support rapid deployment across global study locations.
Epicrispr is advancing EPI-321 with support from a $68 million Series B financing led by Ally Bridge Group and SOLVE FSHD. EPI-321 is the first clinical application of epigenetic gene modulation in neuromuscular disease, and data generated through this study will help define imaging biomarkers for later-phase trials and support regulatory engagement.
About Epicrispr Biotechnologies
Epicrispr Biotechnologies is a biotechnology company pioneering gene-modulating therapies, leading with treatments for neuromuscular diseases. The company's proprietary Gene Expression Modulation System (GEMS) enables precise, durable control of gene expression, unlocking first-in-class treatments for previously untreatable conditions. Epicrispr's lead program, EPI-321 is in clinical trials for FSHD, and the company is advancing additional gene-modulating therapies. Epicrispr also has a research collaboration with Kite Pharma to develop next-generation CAR T-cell therapies. Learn more at www.epicrispr.com or follow us on LinkedIn.
About Springbok Analytics
Springbok Analytics is a leading muscle health analytics company dedicated to advancing health and performance outcomes through innovative, AI-driven solutions that deliver a clearer, more comprehensive view of muscle health.
Built on more than 15 years of research and scientific validation, Springbok's FDA-cleared technology transforms MRI data into personalized, 3D visualizations of muscle health. These detailed analyses provide precise metrics, including individual muscle volume and composition, fat infiltration, asymmetries, scar tissue, edema, and tendon morphology. By offering a more accurate and complete understanding of musculoskeletal health, Springbok enhances diagnostic accuracy, treatment monitoring, research capabilities, and performance optimization.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
25 minutes ago
- Business Insider
X's new head of product said he got the job by posting his way to the top
X's new head of product, Nikita Bier, said he got the job by posting his way to the top. Bier said he spends "every waking hour" on X. In 2022, he tweeted at Elon Musk asking for the product head role. Here's how X's new head of product said he got the job: "I've officially posted my way to the top." Nikita Bier, a Los Angeles-based entrepreneur, posted a picture on X on Monday with the platform's owner, Elon Musk, writing about how he landed his new appointment. "While I already spend every waking hour on this app, I'll now be spending that time helping others unlock that same value," he said in the post. Ladies and gentlemen, I've officially posted my way to the top: I'm joining @X as Head of Product. 𝕏 is the most important social network in the world. It's where internet culture originates and where the world's most influential people convene. Finding my community and… — Nikita Bier (@nikitabier) June 30, 2025 Musk reposted Bier's announcement with the caption, "Welcome to X!" The appointment was a long time coming for Bier — he has had his eye on the role for more than three years. In April 2022, shortly after Musk took over X — which was then called Twitter — Bier tweeted at Musk asking for the role: "@elonmusk Hire me to run Twitter as VP of Product." "Twitter has the potential to be the leading messenger, groups app & content creation tool," he said in the post. Shortly after his appointment on Monday, Bier added the comment "Never give up" to his old post. Bier worked as a Meta product manager from 2017 to 2021. He cofounded tbh, an anonymous polling app for teenagers, which was acquired by Facebook in 2017. Less than a year later, Facebook shut down the app, citing "low usage." Bier also cofounded Gas, a social media app similar in function to tbh. Discord acquired it in January 2023 and shut it down in November. Along with being a serial entrepreneur, Bier is also a serial poster. He posts on X several times daily and has garnered a following of over half a million on the app. Over the years, he has provided Musk with product advice on X. In January 2023, Bier wrote that he would pay Musk $100 to "revert all product changes back" to what they were before he acquired Twitter.
Business Journals
an hour ago
- Business Journals
Wake Forest's Charlotte campus redefines medical education with inaugural class
When Wake Forest University School of Medicine Charlotte opens this July, Charlotte will welcome its first class of 49 medical students to the new campus in The Pearl innovation district. The program will debut a pioneering, case-driven curriculum that immerses students in real-world patient scenarios from day one—reshaping how future physicians are trained. This campus builds on the Winston-Salem-based program and makes problem-based learning the cornerstone of its educational approach. Students and faculty at both campuses share resources, research opportunities and rotations. The connection allows students and faculty to tap into the full resources of the school across both locations, says Roy E. Strowd, M.D., vice dean for undergraduate medical education at Wake Forest University School of Medicine, who travels weekly between both sites. 'There's not that traditional lecture piece that many would be familiar with from their training,' Strowd said. 'The week starts with a case, and that becomes the springboard for self-guided instruction with faculty oversight.' The medical community's response has been unprecedented. When Strowd started recruiting for the first 30 teaching positions, he received nearly 170 applications. With enrollment expected to reach approximately 100 students per class over the next five years, the first Charlotte students will work with as many as 1,000 area physicians during their final two years of clinical rotations. expand Anatomy instruction relies on advanced tools rather than traditional cadaver labs, which allows students to learn anatomy longitudinally throughout their training rather than in isolated blocks. Students use virtual reality systems and plastinated specimens. (Plastination refers to the process of replacing water and fat in biological tissue with durable plastics.) The students also begin ultrasound instruction from day one. 'Wake Forest University School of Medicine is going to have the ability to really change the landscape of what we know about medical education,' Strowd said. The Charlotte campus' home at The Pearl sits just steps from Atrium Health Carolinas Medical Center, a Level I trauma and academic hospital. That proximity supports early clinical exposure through advanced technology and specialized services. The Pearl also hosts IRCAD North America, a world-renowned surgical training center providing expertise in robotics and minimally invasive surgery. Ensuring educational excellence across both locations remains a priority. The School of Medicine maintains consistent academic standards across both campuses. Graduates from Charlotte and Winston-Salem complete the same exams, residency match benchmarks and graduation requirements. Student performance in courses and phases is closely monitored and used to refine instruction. expand This expansion responds to a clear regional need. Charlotte was the nation's largest city without a four-year medical school. North Carolina also has one of the biggest rural populations in the country. The School of Medicine graduates enter primary care at high rates, and many stay in state for residencies. Once both campuses reach full enrollment, the Wake Forest University School of Medicine expects to graduate about 245 doctors per year, making it the largest medical school in the state by enrollment. The model also expands research opportunities for medical students in both cities, with students and faculty engaging in basic science work primarily in Winston-Salem and implementation-based projects in Charlotte. Character development remains central to the School's mission. Like the Winston-Salem campus, the Charlotte campus will focus on developing physicians who demonstrate intellectual humility, curiosity, compassion and courage through community integration and strategic partnerships. 'We're not reinventing what's happening in Charlotte's medical community, we're becoming integrated into what's already there and helping it grow,' Strowd said.
Business Journals
an hour ago
- Business Journals
Innovation district, The Pearl, launches in Charlotte as a blueprint for health care transformation
The Pearl has officially opened its doors, marking the launch of a transformative new model in health care. Strategically uniting leading-edge medical training, academia and the most innovative names in health technology, The Pearl is designed to ignite collaboration, catalyze economic growth and drive innovative solutions for the city, region and beyond. The Charlotte-based innovation district was created by a visionary public-private partnership led by Atrium Health, Wexford Science & Technology, LLC and Ventas. Home to the Charlotte campus of Wake Forest University School of Medicine, the city's first four-year medical school, and the exclusive North American headquarters of IRCAD, a global network of advanced surgical training facilities, The Pearl will be a global destination for medical education and research. 'We built The Pearl to unlock the next era of clinical breakthroughs by uniting the brightest minds with the most advanced technologies in modern medicine,' said Eugene A. Woods, CEO of Advocate Health, of which Atrium Health is a part. 'It's where the world's top medical technology companies will work alongside surgeons, scientists, startups and students from Charlotte's first four-year medical school with the singular goal of finding new treatments and cures. Simply put, it will be a place where excellence lives — and excellence is learned.' Over the next 15 years, the district is projected to generate more than 5,500 on-site jobs and more than 11,500 total jobs across the region, making The Pearl a catalyst for economic growth and opportunity. 'Building vibrant, amenity-rich communities that spark innovation begins by bringing together visionary people and transformative ideas,' said Thomas Osha, executive vice president of Wexford Science & Technology, the developer of The Pearl. 'Grounded in research, discovery, entrepreneurship, corporate partnership and deep community engagement, The Pearl is more than a district — it's the beginning of a bold new chapter in Charlotte's innovation story.' expand At the heart of The Pearl is the Charlotte campus of Wake Forest University School of Medicine. The school of medicine is the academic core of Advocate Health. With its first class of students starting in July, enrollment is expected to increase to 100 students per class over the next five years. 'Complete with a state-of-the-art simulation center, we're reimagining education at Wake Forest University School of Medicine for the next generation of medical professionals,' said Dr. Julie Freischlag, chief academic officer of Advocate Health and CEO of Atrium Health Wake Forest Baptist. 'By integrating traditional learning with real-world experience and community engagement, The Pearl fosters an environment where learning extends far beyond the classroom.' Appealing to different learning styles, the school of medicine's Charlotte campus curriculum takes a unique, problem-based approach to learning, known as integrated biomedical sciences. The approach uses weekly clinical cases as springboards for students to learn foundational science and evaluate possible diagnoses, in addition to considering outside factors that may impact patient outcomes. The Pearl also is home to IRCAD North America, which includes a surgical training curriculum with the latest techniques in cardiovascular, neuro and orthopedic surgeries, among others, all of which are unique to the network. With programs set to begin in September, it's expected to draw thousands of medical professionals from across the globe annually. 'I congratulate Advocate Health on the grand opening of The Pearl, which will help provide lifesaving care to the Charlotte community and foster cutting-edge medical innovation,' said North Carolina Gov. Josh Stein. 'With an estimated 5,500 onsite jobs, The Pearl will also be a boon to Charlotte's economy, strengthen North Carolina's health care network and position our state as a global destination for advancing complex medical care.' expand The commitment to educating the next generation of medical professionals also is evident through Atrium Health's partnership with Charlotte-Mecklenburg Schools. Together, with support from other partners, they've launched a science, technology, engineering and mathematics — or STEM — program designed to help middle school students get excited about careers in health care through free learning opportunities in an on-site lab. 'This innovation district is a powerful symbol of Charlotte's commitment to creating opportunities for everyone who calls this city home,' said Charlotte Mayor Vi Lyles. 'Not only does it honor our past by recognizing the rich history of Brooklyn, but it also looks to create space for inclusive growth.' Located in the area historically known as Brooklyn — once a thriving African American community that was displaced in the 1960s and 1970s — the district is designed to reflect that legacy of resilience. With exhibits that pay homage to Brooklyn's enduring legacy, The Pearl aims to be a place where people from all walks of life will feel welcome and grow together. 'This is an important milestone for our entire community,' said Mark Jerrell, chair of the Mecklenburg Board of County Commissioners. 'This investment has the potential to foster greater opportunities for our residents, scholars and workforce in a way that honors this community's rich history, while also paving the way for a brighter future.' The grand opening, which marked the completion of the first of three phases and includes more than 700,000 square feet of space, included walking tours, performances by local artists, a showcase of community partners and exhibits that reflect both the technological aspirations and the cultural heritage of the neighborhood. National excitement: What others are saying North Carolina Senate President Pro Tempore Sen. Phil Berger: 'The Pearl is more than an innovation district in Charlotte — it's a launchpad for North Carolina's future. By attracting world-class partners like Wake Forest University School of Medicine and IRCAD North America, as well as investing in cutting-edge innovation, The Pearl is driving economic growth, expanding opportunity and helping shape a healthier, more prosperous state. Its impact will stretch far beyond city limits — fueling talent, research and progress that benefits all North Carolinians.' Dr. L. Ebony Boulware, dean of Wake Forest University School of Medicine, chief science officer and vice chief academic officer of Advocate Health: 'As our world is changing, especially with technology advances, we are challenged to rethink everything — how we teach, how students learn and how we prepare the next generation of physicians to lead. This challenge became an opportunity. And our new school of medicine campus at The Pearl is our answer. This is a place where medicine meets technology, where education meets entrepreneurship — and where talent becomes transformation.' Rep. Destin Hall, North Carolina House of Representatives speaker: 'The Pearl stands as one of North Carolina's most significant investments in decades, delivering profound impacts both economically and in human health. By bringing Wake Forest's world-class medical school and its partnership with Atrium Health to Charlotte, they are addressing the state's critical health care needs while generating substantial economic growth and opportunity.' John Kowal, president and head of the Americas at Siemens Healthineers: 'North Carolina is an increasingly important location for our business. The combination of IRCAD North America, Wake Forest University School of Medicine Charlotte and our U.S. Experience Center within The Pearl makes it the ideal site for innovation, collaboration and improved patient care.'
